SCHEMBL29990767

SCHEMBL29990767

Cn1c(=O)n(C2CCC(=O)NC2=O)c2ccc(CCCCCCCn3cc(CC(=O)OC(C)(C)C)cn3)cc21

nearest known ligand 0.50

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 20/20 0.50
▸ DDB1 Q16531 17/20 0.50
▸ IRAK4 Q9NWZ3 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25123219 1.00 CRBN (0.50) CRBNDDB1IRAK4
SCHEMBL29990946 0.90 DDB1 (0.54) CRBNDDB1
SCHEMBL25123105 0.90 DDB1 (0.54) CRBNDDB1
SCHEMBL29991108 0.88 DDB1 (0.43) CRBNDDB1IRAK4
SCHEMBL25123324 0.88 DDB1 (0.43) CRBNDDB1IRAK4
SCHEMBL27166534 0.86 CRBN (0.41) CRBNDDB1
SCHEMBL23842395 0.85 CRBN (0.58) CRBNDDB1
SCHEMBL30289457 0.85 CRBN (0.58) CRBNDDB1
SCHEMBL23842106 0.85 DDB1 (0.64) CRBNDDB1
SCHEMBL25122889 0.85 DDB1 (0.45) CRBNDDB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117715904-A CDK2 degrading agents and uses thereof 凯麦拉医疗公司 2024-03-15 — — CN disclosed
EP-4334307-A1 CDK2 DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2024-03-13 — — EP disclosed
WO-2022236058-A1 CDK2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2022-11-10 — — WO disclosed
Send feedback